RENEW BIOLOGICS Trademark

Trademark Overview


On Sunday, September 22, 2024, a trademark application was filed for RENEW BIOLOGICS with the United States Patent and Trademark Office. The USPTO has given the RENEW BIOLOGICS trademark a serial number of 98763377. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Friday, April 4, 2025. This trademark is owned by Roger C. Sohn, MD. Inc.. The RENEW BIOLOGICS trademark is filed in the Medical & Beauty Services & Agricultural Services category with the following description:

We offer regenerative treatments such as platelet rich plasma injections for musculoskeletal healing.
renew biologics

General Information


Serial Number98763377
Word MarkRENEW BIOLOGICS
Filing DateSunday, September 22, 2024
Status641 - NON-FINAL ACTION - MAILED
Status DateFriday, April 4, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesWe offer regenerative treatments such as platelet rich plasma injections for musculoskeletal healing.

Classification Information


International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateSunday, September 22, 2024
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameRoger C. Sohn, MD. Inc.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressSan Juan Capistrano, CA 92675

Trademark Events


Event DateEvent Description
Sunday, September 22, 2024NEW APPLICATION ENTERED
Thursday, March 27, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, April 4, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, April 4, 2025NON-FINAL ACTION E-MAILED
Friday, April 4, 2025NON-FINAL ACTION WRITTEN
Friday, March 28, 2025ASSIGNED TO EXAMINER